SCHEMBL19872673

SCHEMBL19872673

C=CCOc1ccc(C(=O)NC(C)(C)CCOC(C)(C)CC)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.51
▸ MAPT P10636 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ POLB P06746 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ CHRNB2 P17787 6/20 0.46
▸ CHRNB4 P30926 6/20 0.46
▸ CHRNA3 P32297 6/20 0.46
▸ CHRNA4 P43681 6/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ ADRB2 P07550 1/20 0.43
▸ ADRB1 P08588 1/20 0.43
▸ ADRB3 P13945 1/20 0.43
▸ GAA P10253 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ PLK1 P53350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23870191 0.79 AOC3 (0.40) NPC1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL23870165 0.79 NDUFS8 (0.41) NPC1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL24106084 0.71 AOC3 (0.41) MAPTSMN1; SMN2HPGDHTTLMNA
SCHEMBL24110662 0.71 PLK1 (0.65) NPC1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL21116106 0.70 PLK1 (0.63) NPC1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL18697940 0.69 TRPV1 (0.42) POLBHTTPLK1
SCHEMBL19601257 0.69 NPC1 (0.58) NPC1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL6740785 0.69 ALDH1A1 (0.64) NPC1MAPTRAB9APOLBSMN1; SMN2
SCHEMBL20031971 0.69 HDAC3 (0.45) NPC1RAB9APOLB
SCHEMBL7291413 0.69 SMN1; SMN2 (0.76) NPC1MAPTRAB9APOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180042843-A1 HIGH DENSITY PEPTIDE POLYMERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-02-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180042843-A1 HIGH DENSITY PEPTIDE POLYMERS ERMP1, PARL, PRAP1 NPC1 1559/4885MAPT 2736/4885RAB9A 712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback